Gene · 9221
Papers1,561
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,561
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| STAT3 promotes RNA polymerase III-directed transcription by controlling the miR-106a-5p/TP73 axis. | Elife | 2023 | 36656267 | PubTator, text mining | PubMed |
| Identification of new telomere- and telomerase-associated autoantigens in systemic sclerosis. | J Autoimmun | 2023 | 36634459 | PubTator, text mining | PubMed |
| Evaluation of the proteomic landscape of HPV E7‑induced alterations in human keratinocytes reveal therapeutically relevant pathways for cervical cancer. | Mol Med Rep | 2023 | 36633133 | PubTator, text mining | PubMed |
| Glucose dissociates DDX21 dimers to regulate mRNA splicing and tissue differentiation. | Cell | 2023 | 36608661 | PubTator, text mining | PubMed |
| Co-targeting BCL-XL and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in mice. | Cell Death Discov | 2023 | 36588105 | PubTator, text mining | PubMed |
| Drag-and-drop genome insertion of large sequences without double-strand DNA cleavage using CRISPR-directed integrases. | Nat Biotechnol | 2023 | 36424489 | PubTator, text mining | PubMed |
| Circular RNAs: New layer of complexity evading breast cancer heterogeneity. | Noncoding RNA Res | 2023 | 36380816 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| KEAP1-NRF2 protein-protein interaction inhibitors: Design, pharmacological properties and therapeutic potential. | Med Res Rev | 2023 | 36086898 | PubTator, text mining | PubMed |
| Repression of linc01555 up-regulates angiomotin-p130 via the microRNA-122-5p/clic1 axis to impact vasculogenic mimicry-mediated chemotherapy resistance in small cell lung cancer. | Cell Cycle | 2023 | 36045598 | PubTator, text mining | PubMed |
| MS4A3-HSP27 target pathway reveals potential for haematopoietic disorder treatment in alimentary toxic aleukia. | Cell Biol Toxicol | 2023 | 34581912 | PubTator, text mining | PubMed |
| The Question of Survival or Death: What Is the Role of Autophagy in Acute Myeloid Leukemia (AML)? | Int J Hematol Oncol Stem Cell Res | 2022 | 36883106 | PubTator, text mining | PubMed |
| Label-free LC-MS/MS proteomics analyses reveal CLIC1 as a predictive biomarker for bladder cancer staging and prognosis. | Front Oncol | 2022 | 36727059 | PubTator, text mining | PubMed |
| Genomic and clinical features of endoplasmic reticulum stress factor in digestive system pan-cancer studies. | Front Oncol | 2022 | 36698399 | PubTator, text mining | PubMed |
| CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell Model. | Biomedicines | 2022 | 36672551 | PubTator, text mining | PubMed |
| PARP-1 genetic polymorphism associated with radiation sensitivity of non-small cell lung cancer. | Pathol Oncol Res | 2022 | 36590386 | PubTator, text mining | PubMed |
| Proteomics and Phospho-Proteomics Profiling of the Co-Formulation of Type I and II Interferons, HeberFERON, in the Glioblastoma-Derived Cell Line U-87 MG. | Cells | 2022 | 36552831 | PubTator, text mining | PubMed |
| One-pot chemical pyro- and tri-phosphorylation of peptides by using diamidophosphate in water. | Chem Sci | 2022 | 36544739 | PubTator, text mining | PubMed |
| Systematic comparison of differential expression networks in MTB mono-, HIV mono- and MTB/HIV co-infections for drug repurposing. | PLoS Comput Biol | 2022 | 36534703 | PubTator, text mining | PubMed |
| Effect of CTP-mediated PTEN on 5637 bladder cancer cells and the underlying molecular mechanism. | BMC Urol | 2022 | 36496361 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9221/papers?page=8